atovaquone has been researched along with Epithelial Ovarian Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, B; Guo, Y; Hu, B; Zhu, H | 1 |
1 other study(ies) available for atovaquone and Epithelial Ovarian Cancer
| Article | Year |
|---|---|
Atovaquone at clinically relevant concentration overcomes chemoresistance in ovarian cancer via inhibiting mitochondrial respiration.
Topics: Apoptosis; Atovaquone; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Humans; Mitochondria; Ovarian Neoplasms; Respiration | 2021 |